 |
answer text |
<p>The implantation of a duodenal–jejunal bypass liner, also known as an endo barrier,
for managing type 2 diabetes, is not recommended by the NICE, and therefore not available
on the National Health Service. Current evidence on the safety and efficacy of the
device for managing type 2 diabetes is limited in quality and quantity. For this reason,
the NICE recommends that the procedure should only be done as part of a research study.
Further information on the NICE guidelines is available at the following link:</p><p><a
href="https://www.nice.org.uk/guidance/ipg518/chapter/1-Recommendations" target="_blank">https://www.nice.org.uk/guidance/ipg518/chapter/1-Recommendations</a></p><p>The
NICE may update the guidance, upon publication of further evidence. The NICE recommends
that people with type 2 diabetes receive eight care processes at least annually, to
support them to achieve three treatment targets to prevent diabetes related complications.
The care processes include checks on blood glucose and body mass index, to support
weight management. Delivery of all eight care processes is associated with reduced
emergency admissions, amputations, and retinopathy. NHS England commissions two national
lifestyle services to support adults with type 2 diabetes to manage their weight and
improve their health and wellbeing. These are the NHS Digital Weight Management Programme
and the NHS Type 2 Diabetes Path to Remission Programme. The NICE guidance for the
care and management for adults with type 2 diabetes is available at the following
link:</p><p><a href="https://www.nice.org.uk/guidance/ng28" target="_blank">https://www.nice.org.uk/guidance/ng28</a></p>
|
|
